POMDOCTOR Ltd revenue by segment POM
POMDOCTOR Ltd splits its revenue 2 ways in its filings. By operating segments, the largest line in fiscal 2025, which ended Dec 31, 2025 was pharmaceuticals Supply Chain at $35.6 million, 62% of the total. By sales mix, the largest line in fiscal 2025, which ended Dec 31, 2025 was Pharmacy Wholesale at $34.8 million, 61% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2025
Dec 31, 2025
|
|---|---|
| Revenue |
57
|
| Operating segments | |
| pharmaceuticals Supply Chain |
36
share 62.3%
|
| Internet Hospital |
22
share 37.7%
|
| Sales mix | |
| Pharmacy Wholesale |
35
share 60.8%
|
| Online Pharmacy Sales And Other Sales Revenue |
21
share 37.3%
|
| Pharmacy Retail Sales |
1
share 1.5%
|
| Online Consultation Service And Other Service Revenue |
0
share 0.4%
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. More on our methodology.
Company profile
- Industry
- Retail-Miscellaneous Retail (SIC 5900)
- Listed as
- POM (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Guangzhou
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1877971
Other Retail-Miscellaneous Retail companies
- FirstCash Holdings, Inc. FCFS
- Ezcorp Inc EZPW
- TheRealReal, Inc. REAL
- Savers Value Village, Inc. SVV
- Suburban Propane Partners LP SPH
- Winmark Corp WINA
- Teamshares Inc TMS
- Ferrellgas Partners L P FGPR
Source: SEC EDGAR filings. This is company-reported data, not investment advice.